Golden State Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.5K | Sell |
20
-6
| -23% | -$3.15K | ﹤0.01% | 1067 |
|
2025
Q1 | $16.5K | Hold |
26
| – | – | ﹤0.01% | 849 |
|
2024
Q4 | $18.5K | Buy |
+26
| New | +$18.5K | ﹤0.01% | 785 |
|
2022
Q1 | $274K | Sell |
393
-6
| -2% | -$4.18K | 0.05% | 251 |
|
2021
Q4 | $252K | Sell |
399
-30
| -7% | -$18.9K | 0.04% | 318 |
|
2021
Q3 | $260K | Sell |
429
-9
| -2% | -$5.46K | 0.06% | 251 |
|
2021
Q2 | $245K | Buy |
438
+1
| +0.2% | +$559 | 0.05% | 254 |
|
2021
Q1 | $206K | Buy |
+437
| New | +$206K | 0.07% | 194 |
|
2020
Q2 | – | Sell |
-300
| Closed | -$146K | – | 719 |
|
2020
Q1 | $146K | Buy |
+300
| New | +$146K | 0.06% | 194 |
|